LITYNDA Trademark

Trademark Overview

On Friday, October 21, 2005, a trademark application was filed for LITYNDA with the United States Patent and Trademark Office. The USPTO has given the LITYNDA trademark a serial number of 79020242. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, July 2, 2022. This trademark is owned by Novartis AG. The LITYNDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, for the treatment of diabetes, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in haematology, in transplantation and in ophthalmology, for use in the gastroenterological area and for the prevention and treatment of ocular disorders or diseases; anti-infectives; pharmaceutical preparations for treatment of bacteria-based diseases; antivirals; antibiotics; anti-fungals
litynda

General Information

Serial Number79020242
Word MarkLITYNDA
Filing DateFriday, October 21, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, July 2, 2022
Registration Number3184113
Registration DateTuesday, December 12, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 26, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, for the treatment of diabetes, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in haematology, in transplantation and in ophthalmology, for use in the gastroenterological area and for the prevention and treatment of ocular disorders or diseases; anti-infectives; pharmaceutical preparations for treatment of bacteria-based diseases; antivirals; antibiotics; anti-fungals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 4, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, January 30, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, January 30, 2023DEATH OF INTERNATIONAL REGISTRATION
Friday, June 5, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, December 17, 2014GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, December 17, 2014GENERIC MADRID TRANSACTION CREATED
Wednesday, June 4, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 4, 2013CANCELLED SECTION 71
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, November 3, 2012INTERNATIONAL REGISTRATION RENEWED
Sunday, June 28, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 28, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 18, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 19, 2007FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 19, 2007FINAL DISPOSITION PROCESSED
Tuesday, July 10, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 12, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, September 26, 2006PUBLISHED FOR OPPOSITION
Wednesday, September 6, 2006NOTICE OF PUBLICATION
Friday, August 4, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 14, 2006ASSIGNED TO LIE
Friday, June 30, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 29, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, June 29, 2006EXAMINERS AMENDMENT E-MAILED
Thursday, June 29, 2006EXAMINERS AMENDMENT -WRITTEN
Monday, June 19, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 19, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 18, 2006REFUSAL PROCESSED BY IB
Monday, May 1, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 1, 2006REFUSAL PROCESSED BY MPU
Friday, April 28, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 28, 2006NON-FINAL ACTION WRITTEN
Tuesday, April 25, 2006ASSIGNED TO EXAMINER
Friday, February 24, 2006NEW APPLICATION ENTERED
Thursday, February 23, 2006SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

litynda system treatment disorders diseases preparations anti prevention pharmaceutical gastroenterological area